Hormonālās un intīmās labsajūtas pētījumi.

PT-141 (bremelanotide): the melanocortin that got an approval — for one indication only

Two phase 3 trials, an FDA-approved product and a published critique of its own endpoints. This is the rare compound where the human data exists, and where reading it carefully changes what you can claim.